Care of the incarcerated cancer patient Maurie Markman Editor’s Commentary 20 April 2007 Pages: 81 - 82
Sunitinib in advanced renal cell carcinoma: New treatment option Ronald M. Bukowski Clinical trials report 20 April 2007 Pages: 87 - 88
The platelet-derived growth factor receptor as a therapeutic target Nancy L. Lewis OriginalPaper 20 April 2007 Pages: 89 - 95
Cyclooxygenase-2: A novel target in human solid tumors Maria Rosaria RaspolliniGian Luigi Taddei OriginalPaper 20 April 2007 Pages: 96 - 101
c-Met and hepatocyte growth factor: Potential as novel targets in cancer therapy Martin SattlerRavi Salgia OriginalPaper 20 April 2007 Pages: 102 - 108
Drug distribution in tumors: Mechanisms, role in drug resistance, and methods for modification Antonello Di PaoloGuido Bocci OriginalPaper 20 April 2007 Pages: 109 - 114
Pazopanib: A novel multitargeted tyrosine kinase inhibitor Guru SonpavdeThomas E. Hutson OriginalPaper 20 April 2007 Pages: 115 - 119
Lenalidomide: Immunomodulatory, antiangiogenic, and clinical activity in solid tumors Robert Dreicer OriginalPaper 20 April 2007 Pages: 120 - 123
Epidermal growth factor receptor inhibitors and radiotherapy for patients with cancer of the head and neck Ehab Y. Hanna Clinical trials report 20 April 2007 Pages: 127 - 128
Induction chemotherapy for squamous cancer of the head and neck Merrill S. Kies OriginalPaper 20 April 2007 Pages: 129 - 133
Contemporary management of tumors of the salivary glands Joseph M. SciannaGuy J. Petruzzelli OriginalPaper 20 April 2007 Pages: 134 - 138
Occult primary head and neck carcinoma Cecelia E. SchmalbachFrank R. Miller OriginalPaper 20 April 2007 Pages: 139 - 146
Cancer of the paranasal sinuses Sandeep SamantEmma Kruger OriginalPaper 20 April 2007 Pages: 147 - 151
Anaplastic thyroid carcinoma: An overview Wendy R. CornettAnand K. SharmaJyotika K. Fernandes OriginalPaper 20 April 2007 Pages: 152 - 158